Indian Journal of Animal Research

Indian Journal of Animal Research cover
Volume 59 · Issue 11 · 2025/04/04

Hypolipidemic, Antioxidant and Anti-atherosclerogenic Effect of Catalpol in Hypercholesterolemic Induced Rats

Xiaohua Zhang
Xiaofeng Ma
237 Views

Submitted

2024/12/06

First Online

2025/04/04

doi

10.18805/IJAR.BF-1936

Cite article - Xiaohua Zhang, Xiaofeng Ma. (2025). Hypolipidemic, Antioxidant and Anti-atherosclerogenic Effect of Catalpol in Hypercholesterolemic Induced Rats. Indian Journal of Animal Research. 59(11): 1917–1922. doi: 10.18805/IJAR.BF-1936

Abstract

Background: Atherosclerosis, oxidative stress and hyperlipidemia are major risk factors in the pathogenesis of cardiovascular diseases. Cardiovascular diseases are public health problem all over world and constitute more than 17 million deaths in a year. Catalpol is well-known is an iridoid glucoside found in the roots of Rehmanniaglutinosa and known to have several protective effect against diabetic encephalopathy, neurotoxicity and hyperglycemia. The present study was aimed to analyze the hypolipidemic, anti-atherosclerogenic and antioxidant effect of catalpol in hyperlipidemic induced rats.

Methods: Rats were grouped into normal control, hyperlipidemic, hyperlipidemic + 10 mg/kg of catalpol, hyperlipidemic + 20 mg/kg of catalpol and hyperlipidemic + 10 mg/kg of simvastatin. Treatment was administered orally for 45 consecutive days.

Result: Hyperlipidemic rats treated with catalpol and simvastatin significantly reduced excessive body weight gain. Lipid peroxidation was reduced 36.4% and 115.2% at 10 and 20 mg/kg of catalpol. Hyperlipidemic rats treated with catalpol and simvastatin significantly improved the catalase, glutathione peroxidase (Gpx), superoxide dismutase (SOD) and reduced glutathione (GSH) in the serum to the near normal range, whereas HMG-CoA reductase, total cholesterol, liver enzymes in the liver tissues were reduced significantly. Furthermore, catalpol treatment reduced the serum level triglycerides, total cholesterol, low-density lipoprotein (LDL) and very low-density lipoprotein (VLDL) and increased the high-density lipoprotein (HDL). Taking all these data together, catalpol supplementation appears to function as an anti-hyperlipidemic agent in Triton WR 1339-induced hyperlipidemic rats.

References

  1. Bao, M.H., Li, G.Y., Huang, X.S., Tang, L., Dong, L.P. and Li, J.M. (2018). Long noncoding RNA LINC00657 acting as a miR-590-3p sponge to facilitate low concentration oxidized low-density lipoprotein-induced angiogenesis. Molecular Pharmacology . 93: 368-375. Baskaran, G., Salvamani, S., Ahmad, S.A., Shaharuddin, N.A., Pattiram, P.D. and Shukor, M.Y. (2015). HMG-CoA reductase inhibitory activity and phytocomponent investigation of Basella alba leaf extract as a treatment for hypercholesterolemia. Drug Design, Development and Therapy . 9: 509-517. Bhattamisra, S.K., Yap, K.H., Rao, V. and Choudhury, H. (2019). Multiple biological effects of an iridoid glucoside, catalpol and its underlying molecular mechanisms. Biomolecules . 10. Chen, J., Chen, Q., Xiao, P., Jin, W. and Yu, L. (2025). A novel framework for uncovering the coordinative spectrum- effect correlation of the effective components of Yangyin Tongnao Granules on cerebral ischemia-reperfusion injury in rats. Journal of Ethnopharmacology . 337: 118844. Chen, Z., Liu, J., Wang, A., Wu, B., Cheng, Z., Jiang, Y., Gu, H., Ding, L., Mo, J., Liu, L., Jing, L., Jing, J., Wang, Y., Zhao, X., Qin, H. and Li, Z. (2024). Hemodynamic impairment of blood pressure and stroke mechanisms in symptomatic intracranial atherosclerotic stenosis. Stroke . 55: 1798-1807. Devi, G., Umesh, D., Ajith, Y., Deepa, P.M., Yatoo M.I., Gopalakrishnan A. and Madhesh E. (2023). The anti-oxidant and the anti-diabetic effects of terminalia chebula and Withania somnifera in subclinically diabetic dogs. Indian Journal of Animal Research . 57: 1042-1050. doi: 10.18805/IJAR. B-4355 . Feng, S., Cao, M., Tang, P., Deng, S., Chen, L., Tang, Y., Zhu, L., Chen, X., Huang, Z., Shen, M. and Yang, F. (2023). Microcystins exposure associated with blood lipid profiles and dyslipidemia: A cross-sectional study in hunan province, China. Toxins . 15. Fidele, N., Joseph, B., Emmanuel, T. and Theophile, D. (2017). Hypolipidemic, antioxidant and anti-atherosclerogenic effect of aqueous extract leaves of Cassia occidentalis Linn (Caesalpiniaceae) in diet-induced hypercholesterolemic rats. BMC Complementary and Alternative Medicine . 17: 76. Fu, Z., Su, X., Zhou, Q., Feng, H., Ding, R. and Ye, H. (2023). Protective effects and possible mechanisms of catalpol against diabetic nephropathy in animal models: A systematic review and meta-analysis. Frontiers in Pharmacology . 14: 1192694. Hermans, M.P. and Valensi, P. (2018). Elevated triglycerides and low high-density lipoprotein cholesterol level as marker of very high risk in type 2 diabetes. Current Opinion In Endocrinology, Diabetes and Obesity . 25: 118-129. Hu, R. and Feng, H. (2017). Lenticulostriate artery and lenticulostriate- artery neural complex: New concept for intracerebral hemorrhage. Current Pharmaceutical Design . 23: 2206-2211. Khalid, A.M., Fayyaz, R., Ehsan, B.M., Samina, L., Muhammad, Y.Z., Shafaq, Z., Noor, K. and Muhammad, Y. (2019). Comparative hypolipidemic efficacy of homeopathic mother tincture Allium sativa Q, Curcuma longa Q and statin in normal and cholesterol fed rabbits. Indian Journal of Animal Research . 53(8): 1029-1032. doi: 10.18805/ijar.B-966 . Khan, S.M., Sobti, R.C. and Kataria, L. (2005). Pesticide-induced alteration in mice hepato-oxidative status and protective effects of black tea extract. Clinica Chimica Acta; International Journal of Clinical Chemistry . 358: 131-138. Liu, J., Liu, S., Yu, M., Li, J., Xie, Z., Gao, B. and Liu, Y. (2023). Anti- inflammatory effect and mechanism of catalpol in various inflammatory diseases. Drug Development Research . 84: 1376-1394. Liu, J.Y., Zheng, C.Z., Hao, X.P., Zhang, D.J., Mao, A.W. and Yuan, P. (2016). Catalpol ameliorates diabetic atherosclerosis in diabetic rabbits. American Journal of Translational Research . 8: 4278-4288. Lu, Y., Cui, X., Zhang, L., Wang, X., Xu, Y., Qin, Z., Liu, G., Wang, Q., Tian, K., Lim, K.S., Charles, C.J., Zhang, J. and Tang, J. (2022). The functional role of lipoproteins in atherosclerosis: Novel directions for diagnosis and targeting therapy. Aging and Disease . 13: 491-520. Lumu, W., Bahendeka, S., Wesonga, R., Kibirige, D., Kasoma, R.M.and Ssendikwanawa, E. (2023). Atherogenic index of plasma and its cardiovascular risk factor correlates among patients with type 2 diabetes in Uganda. African Health Sciences . 23: 515-527. Luo, J., Wang, L., Cui, C., Chen, H., Zeng, W. and Li, X. (2024). MicroRNA-19a-3p inhibits endothelial dysfunction in atherosclerosis by targeting JCAD. BMC Cardiovascular Disorders . 24: 394. Maruthappan, V. and Shree, K.S. (2010). Effects of phyllanthus reticulatus on lipid profile and oxidative stress in hypercholesterolemic albino rats. Indian Journal of Pharmacology . 42: 388-91. Men, X., Shi, X., Xu, Q., Liu, M., Yang, H., Wang, L. and Xu, H. (2024). Exploring the pathogenesis of chronic atrophic gastritis with atherosclerosis via microarray data analysis. Medicine . 103: e37798. Powell-Wiley, T.M., Poirier, P., Burke, L.E., Despres, J.P., Gordon- Larsen, P., Lavie, C.J., Lear, S.A., Ndumele, C.E., Neeland, I.J., Sanders, P. and St-Onge, M.P. (2021). Obesity and cardiovascular disease: A scientific statement from the American heart association. Circulation . 143: e984-e1010. Ramalingam, N., Ramasamy, M., Arumugam, A.V., Ahmad, A.R., Aiman, A.A. and Anis, A. (2024). Hypolipidemic and cardioprotective efficacy of peltophorum pterocarpum linn in doxorubicin induced cardiotoxicity in rats. Indian Journal of Animal Research . 58(12): 2191-2197. doi: 10.18805/IJAR.B-5430 . Roth, G.A., Mensah, G.A., Johnson, C.O., Addolorato, G., Ammirati, E., Baddour, L.M., Barengo, N.C., et al. (2020). Global burden of cardiovascular diseases and risk factors, 1990-2019: Update from the GBD 2019 study. Journal of the American College of Cardiology . 76: 2982-3021. Shen, Y., Cheng, L., Xu, M., Wang, W., Wan, Z., Xiong, H., Guo, W., Cai, M. and Xu, F. (2023). SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis. Metabolism: Clinical and Experimental . 146: 155657. Shrestha, P., Adepu, S., Vives, R.R., Masri, R.E., Klooster, A., Kaptein, F., Dam, W., Bakker, S.J.L., Van Goor, H., Van De Sluis, B. and Van Den Born, J. (2021). Hypercholesterolemia in progressive renal failure is associated with changes in hepatic heparan sulfate - PCSK9 interaction. Journal of the American Society of Nephrology : JASN . 32: 1371-1388. Sikarwar, M.S. and Patil, M.B. (2012). Antihyperlipidemic activity of Salacia chinensis root extracts in triton-induced and atherogenic diet-induced hyperlipidemic rats. Indian Journal of Pharmacology . 44: 88-92. Tucker, J.J. and Soslowsky, L.J. (2016). Effect of simvastatin on rat supraspinatus tendon mechanical and histological properties in a diet-induced hypercholesterolemia model. Journal of Orthopaedic Research . 34: 2009-2015. Wang, W.Z., Liu, C., Luo, J.Q., Lei, L.J., Chen, M.H., Zhang, Y.Y., Sheng, R., Li, Y.N., Wang, L., Jiang, X.H., Xiao, T.M., Zhang, Y.H., Li, S. W., Wu, Y.X., Xu, Y., Xu, Y.N. and Si, S.Y. (2024). A novel small-molecule PCSK9 inhibitor E28362 ameliorates hyperlipidemia and atherosclerosis. Acta Pharmacologica Sinica . 45: 2119-2133. Zarei, A., Vaezi, G., Malekirad, A.A. and Abdollahi, M. (2015). Effects of ethanol extract of Salvia hydrangea on hepatic and renal functions of streptozotocin-induced diabetic rats. Avicenna Journal of Phytomedicine . 5: 138-147. Zarzecki, M.S., Araujo, S.M., Bortolotto, V.C., De Paula, M.T., Jesse, C.R. and Prigol, M. (2014). Hypolipidemic action of chrysin on Triton WR-1339-induced hyperlipidemia in female C57BL/6 mice. Toxicology Reports . 1: 200-208. Zhao, Y., Hu, J., Sun, X., Yang, K., Yang, L., Kong, L., Zhang, B., Li, F., Li, C., Shi, B., Hu, K., Sun, A. and Ge, J. (2021). Loss of m6A demethylase ALKBH5 promotes post-ischemic angiogenesis via post-transcriptional stabilization of WNT5A. Clinical and Translational Medicine . 11: e402. Zhu, H., Wang, Y., Liu, Z., Wang, J., Wan, D., Feng, S., Yang, X. and Wang, T. (2016). Antidiabetic and antioxidant effects of catalpol extracted from Rehmannia glutinosa (Di Huang) on rat diabetes induced by streptozotocin and high-fat, high-sugar feed. Chinese Medicine . 11: 25.
EDITORIAL BOARD

Guided by Experienced Academic Leadership

Distinguished scholars and subject experts committed to editorial excellence, scientific integrity and rigorous peer review.

View Full Board
Yashpal Singh Malik
Chief Editor

Yashpal Singh Malik

Deputy Director General (Agricultural Education)Indian Council of Agricultural Research, Headquarters, New Delhi , India

L.D. Singla
Associate chief editor

L.D. Singla

Professor and HeadAbhilashi University, Chachyot, Himachal Pradesh, India

Vilas G. Atkare
Editor

Vilas G. Atkare

DeanDr. Panjabrao Deshmukh Krishi Vidyapeeth, Akola, Krishi Nagar, Maharashtra, India

S. Maya
Editor

S. Maya

Associate Dean and Professor & HeadKerala Veterinary and Animal Sciences University, Mannuthy, Thrissur, Kerala, India